Latest Competition News

Enova Mining has successfully raised $2 million through a heavily oversubscribed share placement, enabling accelerated drilling and test work at its East Salinas and Charley Creek projects. This capital injection positions the company to advance its critical minerals exploration amid growing demand for rare earth elements.

Pro Medicus has reported its strongest half-year performance yet, with revenue and profits surging alongside a wave of new multi-million dollar contracts and strategic AI investments. The healthcare IT leader is expanding its global footprint and cloud capabilities, setting the stage for sustained growth.

Aguia Resources is poised to commence production at its Tres Estradas phosphate mine with infrastructure nearly complete and key licenses expected imminently. Meanwhile, exploration at the nearby Passo Feio project reveals promising phosphate grades, underpinning a strong market outlook amid global supply constraints.

Paladin Energy reported a stronger half-year performance with US$138.3 million revenue from uranium sales, a narrowed net loss, and a successful A$400 million equity raise to fund growth projects.

ASX Limited has announced a fully franked ordinary dividend of AUD 1.018 per share for the half-year ending December 2025, offering shareholders a dividend reinvestment plan with a 2.5% discount.

Pro Medicus Limited has reported a stellar half-year performance with revenue up 28.4% and a surge in net profit, driven by major US contract wins and strategic investments.

The US Department of Commerce has finalized hefty antidumping and countervailing duties on Chinese graphite active anode materials, a move expected to strengthen Syrah Resources’ competitive edge in North America and accelerate its US operations.

Matsa Resources launches a major drilling campaign at Fortitude North targeting up to 1.85 million ounces of gold, supported by a $17.5 million loan facility from major shareholder Deutsche Balaton.

AMP Limited's FY25 Data Pack highlights steady earnings with an underlying NPAT of $285 million, supported by strong Platforms net cashflows and a stable capital position. The report offers a detailed breakdown of business unit performance, costs, and market share.

AMP Limited reported a 20.8% rise in underlying net profit after tax for 2025, driven by growth in wealth platforms and investments, alongside a planned CEO transition and pending class action settlements.

Entropy Neurodynamics has been granted an Australian patent for its novel two-phase IV infusion method administering psilocybin and psilocin, securing exclusive rights through 2042 and strengthening its lead asset TRP-8803’s competitive position.

Viva Leisure has reported a robust half-year performance with underlying NPAT up 46.8% and revenue climbing to $116.5 million, driven by strong organic membership growth and a booming technology segment.